Nippon Life Global Investors Americas Inc. Acquires Shares of 6,620 AMETEK, Inc. $AME

Nippon Life Global Investors Americas Inc. bought a new position in shares of AMETEK, Inc. (NYSE:AMEFree Report) during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund bought 6,620 shares of the technology company’s stock, valued at approximately $1,602,000.

Other large investors have also modified their holdings of the company. Mitsubishi UFJ Asset Management Co. Ltd. grew its stake in AMETEK by 6.2% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 487,238 shares of the technology company’s stock valued at $101,901,000 after acquiring an additional 28,621 shares during the last quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund acquired a new position in AMETEK during the fourth quarter worth about $1,027,000. Fifth Third Bancorp lifted its holdings in shares of AMETEK by 1,060.3% in the first quarter. Fifth Third Bancorp now owns 82,948 shares of the technology company’s stock valued at $17,781,000 after purchasing an additional 75,799 shares in the last quarter. Wescott Financial Advisory Group LLC purchased a new stake in shares of AMETEK in the fourth quarter valued at about $1,122,000. Finally, Investment Management Corp VA ADV acquired a new stake in shares of AMETEK in the fourth quarter valued at approximately $496,000. 87.43% of the stock is owned by hedge funds and other institutional investors.

AMETEK Stock Performance

Shares of AME opened at $254.98 on Monday. AMETEK, Inc. has a 1 year low of $179.24 and a 1 year high of $261.16. The company’s 50 day simple moving average is $238.97 and its 200 day simple moving average is $231.27. The company has a market capitalization of $58.44 billion, a price-to-earnings ratio of 37.28, a PEG ratio of 3.26 and a beta of 0.98. The company has a debt-to-equity ratio of 0.09, a quick ratio of 0.76 and a current ratio of 1.21.

AMETEK (NYSE:AMEGet Free Report) last released its earnings results on Tuesday, August 4th. The technology company reported $2.09 EPS for the quarter, topping the consensus estimate of $1.99 by $0.10. The firm had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $1.95 billion. AMETEK had a net margin of 20.04% and a return on equity of 16.93%. AMETEK’s revenue for the quarter was up 15.0% on a year-over-year basis. During the same period in the previous year, the company earned $1.78 EPS. AMETEK has set its Q3 2026 guidance at 2.080-2.100 EPS and its FY 2026 guidance at 8.200-8.300 EPS. On average, sell-side analysts predict that AMETEK, Inc. will post 8.33 EPS for the current year.

AMETEK Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Tuesday, September 15th will be given a $0.34 dividend. The ex-dividend date of this dividend is Tuesday, September 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.5%. AMETEK’s payout ratio is currently 19.88%.

Analysts Set New Price Targets

Several research analysts recently issued reports on the company. BNP Paribas Exane lifted their price objective on AMETEK from $270.00 to $280.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 5th. KeyCorp increased their target price on AMETEK from $260.00 to $295.00 and gave the company an “overweight” rating in a report on Wednesday, August 5th. DA Davidson boosted their price target on AMETEK from $265.00 to $285.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Rothschild & Co Redburn set a $265.00 price objective on AMETEK in a research report on Thursday, June 18th. Finally, TD Cowen reaffirmed a “buy” rating on shares of AMETEK in a research note on Thursday, August 6th. One equities research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $266.80.

Check Out Our Latest Report on AME

Insider Activity at AMETEK

In related news, insider David F. Hermance sold 6,608 shares of the stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $254.00, for a total transaction of $1,678,432.00. Following the transaction, the insider directly owned 42,509 shares in the company, valued at approximately $10,797,286. This represents a 13.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.54% of the stock is currently owned by corporate insiders.

AMETEK Company Profile

(Free Report)

AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.

The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.

Read More

Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AMEFree Report).

Institutional Ownership by Quarter for AMETEK (NYSE:AME)

Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.